Topas Therapeutics

COUR Pharma

This clinical-stage biotechnology company develops nanoparticle therapies designed to restore immune tolerance for patients with autoimmune and inflammatory diseases.

Selecta Biosciences

This biopharmaceutical company develops nanoparticle immunomodulatory drugs to treat and prevent human diseases for patients with autoimmune disorders and rare genetic conditions.

Apitope

Apitope develops antigen-specific peptide therapeutics to treat autoimmune diseases and allergies for patients requiring targeted immunotherapy and immune tolerance restoration.

Tolerance Bio, Inc.

This biopharmaceutical company develops thymus-based therapies to treat immune-mediated diseases including cancer, autoimmunity and transplant rejection for patients requiring restored immune tolerance.

Egle Therapeutics

This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.

Toleranzia

This company develops drugs using an immune tolerance platform to treat patients with rare autoimmune diseases, such as myasthenia gravis.

Zag Bio

This biotechnology company develops thymus-targeted bifunctional antibodies that deliver antigens to induce immune tolerance in patients with autoimmune diseases such as type 1 diabetes.

Aboleris Pharma

This biopharmaceutical company develops immunomodulatory antibodies to treat autoimmune diseases and organ transplantation rejection for patients requiring restored immune tolerance.